{"id":"https://openalex.org/W90572344","doi":null,"title":"Hepatotoxicity in patients prescribed efavirenz or nevirapine.","display_name":"Hepatotoxicity in patients prescribed efavirenz or nevirapine.","publication_year":2008,"publication_date":"2008-07-28","ids":{"openalex":"https://openalex.org/W90572344","mag":"90572344","pmid":"https://pubmed.ncbi.nlm.nih.gov/18700192"},"language":"en","primary_location":{"id":"pmid:18700192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18700192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medical research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038325782","display_name":"Sandra Br\u00fcck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sandra Br\u00fcck","raw_affiliation_strings":["Department of Dermatology, University of Heidelberg, Germany. sandrabrueck@gmx.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Heidelberg, Germany. sandrabrueck@gmx.de","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S Witte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Witte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059468658","display_name":"J\u00fcrgen Brust","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Brust","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109903390","display_name":"Dieter Schuster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Schuster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042631906","display_name":"Franz Mosthaf","orcid":"https://orcid.org/0000-0002-1146-5036","observed_orcids":["https://orcid.org/0000-0002-1146-5036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Mosthaf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010228066","display_name":"Maria Procaccianti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Procaccianti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089104553","display_name":"J. A. Rump","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A Rump","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037590928","display_name":"Hartwig Klinker","orcid":"https://orcid.org/0000-0001-7140-6786","observed_orcids":["https://orcid.org/0000-0001-7140-6786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Klinker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059631093","display_name":"Dieter R. Petzold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Petzold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M Hartmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hartmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.6615,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.9458826,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"13","issue":"7","first_page":"343","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.18529999256134033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9559999704360962},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":1.0},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8999999761581421},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9850000143051147},{"id":"https://openalex.org/keywords/liver-enzymes","display_name":"liver enzymes","score":0.5979999899864197},{"id":"https://openalex.org/keywords/hepatitis-c-coinfection","display_name":"hepatitis C coinfection","score":0.9079999923706055},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.954351544380188},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9348015189170837},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8154627084732056},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6754082441329956},{"id":"https://openalex.org/C3020359197","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver enzyme","level":2,"score":0.5723630785942078},{"id":"https://openalex.org/C2778606649","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine transaminase","level":2,"score":0.5003461837768555},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48036226630210876},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4787306487560272},{"id":"https://openalex.org/C2992872382","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine aminotransferase","level":2,"score":0.4487348198890686},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.431412011384964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3334002196788788},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.314583957195282},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.26655709743499756},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.2241927683353424},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22400322556495667},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:18700192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18700192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medical research","raw_type":"Journal Article"},{"id":"mag:90572344","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18700192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034482023","https://openalex.org/W2084000360","https://openalex.org/W2140561708","https://openalex.org/W1481716359","https://openalex.org/W93928404","https://openalex.org/W2734877172","https://openalex.org/W2068781014","https://openalex.org/W1486786706","https://openalex.org/W1964757363","https://openalex.org/W2128059827"],"abstract_inverted_index":{"AIM:":[0],"For":[1],"several":[2],"years":[3],"Nonnucleoside":[4],"reverse":[5],"transciptase":[6],"inhibitors":[7],"(NNRTIs)":[8],"in":[9,68,89,122,153,171,182,191,202,289,294],"antiretroviral":[10,74],"therapy":[11,75,270],"have":[12],"been":[13],"associated":[14],"with":[15,42,76,229,243,271],"hepatic":[16],"side":[17],"effects.":[18],"Particularly":[19],"the":[20,37,101,123,138,221,255],"hepatotoxic":[21],"potential":[22],"of":[23,39,44,103,114,125,137,157,163,179,188,208,211,225,233,239,257,266],"Nevirapine":[24,45],"is":[25],"well":[26],"analysed":[27],"today.":[28],"We":[29],"performed":[30],"a":[31,132],"prospective,":[32],"multicenter":[33],"study":[34,57,222],"to":[35,48,168,246],"compare":[36],"hepatotoxicity":[38,165,196,215,259],"Efavirenz":[40],"(EFV)":[41,204],"that":[43,136],"(NVP)":[46,207],"and":[47,64,83,94,109,147,155,186,205,213,237,282],"investigate":[49],"further":[50],"risk":[51,252],"factors.":[52],"MATERIAL":[53],"AND":[54],"METHODS:":[55],"The":[56,160],"included":[58,105],"HIV-1-infected":[59],"patients":[60,88,183,192,227,241,290,295],"from":[61,135],"five":[62],"clinics":[63],"private":[65],"medical":[66],"practices":[67],"southwestern":[69],"Germany":[70],"who":[71,130],"initiated":[72],"an":[73],"NVP":[77,272],"or":[78,273],"EFV":[79,93,185,274,292],"between":[80,220],"July":[81],"1998":[82],"December":[84],"2001.":[85],"Among":[86],"296":[87],"total,":[90],"151":[91,180],"received":[92,96],"145":[95,189],"NVP.":[97,194,297],"Laboratory":[98],"tests":[99],"during":[100,269],"course":[102],"treatment":[104],"liver":[106,234,267],"enzymes,":[107],"HIV-RNA":[108],"CD4":[110],"cell-count.":[111],"Additionally,":[112],"signs":[113],"clinical":[115],"hepatitis":[116,148,261],"were":[117,151,249],"recorded.":[118],"Hepatotoxicity":[119],"was":[120,177,200,260],"graded":[121],"manner":[124],"Sulkowsky":[126],"et":[127],"al.":[128],"(2000),":[129],"used":[131],"scale":[133],"modified":[134],"AIDS":[139],"Clinical":[140],"Trials":[141],"Group.":[142],"RESULTS:":[143],"Hepatitis":[144],"C":[145,262],"virus":[146,150],"B":[149],"detected":[152],"10.1%":[154],"4.1%":[156],"patients,":[158],"respectively.":[159],"overall":[161],"rate":[162],"severe":[164,214],"(grade":[166,197],"3":[167,187,224,245],"4":[169,238,247],"elevations":[170],"aspartate":[172],"aminotransferase":[173],"and/or":[174],"alanine":[175],"aminotransferase)":[176],"2":[178,198,231],"(1.3%)":[181],"prescribed":[184,193,291,296],"(2.1%)":[190,228],"Mild-to-moderate":[195],"elevation)":[199],"observed":[201],"6.0%":[203],"3.4%":[206],"patients.":[209],"Incidence":[210],"mild-to-moderate":[212,258,281],"did":[216],"not":[217,276],"differ":[218],"significantly":[219],"groups.":[223],"14":[226],"grade":[230,244],"elevation":[232],"enzymes":[235,268],"(LEE)":[236],"5":[240],"(80%)":[242],"LEE":[248,284],"symptomatic.":[250],"Only":[251],"factor":[253],"for":[254],"development":[256],"coinfection.":[263],"CONCLUSION:":[264],"Increases":[265],"are":[275,279],"unusual,":[277],"but":[278],"mostly":[280],"asymptomatic.":[283],"occurs":[285],"just":[286],"as":[287,293],"frequent":[288]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}